Biotech Clearmind buys 51% of EV charging startup for $2.5M
What's the deal? Clearmind MedicineDealroom has a profile for this one. Try Dealroom →, a Nasdaq-listed biotech, has signed a definitive agreement to acquire a 51% majority stake in Charging RoboticsDealroom has a profile for this one. Try Dealroom →, a wireless EV charging provider, for $2.5 million. The deal is expected to close during the week of September 7, 2026, subject to certain closing conditions.
What does Charging Robotics do? It builds intelligent wireless charging systems for automated parking facilities, autonomous mobile platforms, and robotaxi operations — settings where cables and plug-in infrastructure fall short.
The terms: Alongside the purchase, Clearmind will extend a $1.5 million loan to Charging Robotics at 4% annual interest. Unless repaid earlier, the principal and accrued interest fall due on the three-year anniversary of the closing.
What's the endgame? The move marks a sharp pivot for Clearmind, a company focused on psychedelic-based treatments, into the electric vehicle charging market. Taking a controlling stake gives it a foothold in infrastructure aimed at autonomous and driverless transport.
The signal: A biotech buying into EV charging is an unusual cross-sector bet, reflecting how far smaller listed firms will reach for growth beyond their core markets. Whether Clearmind can operate a robotics business remains the open question.
Read more: finanzen.at
Image credit: Generated with Gemini
